Patents by Inventor Ulf Hedin

Ulf Hedin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS TO AID CLINICAL DECISION SUPPORT FOR COMBINATION THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20240087742
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 14, 2024
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • SYSTEMS AND METHODS TO AID CLINICAL DECISION SUPPORT FOR GLYCEMIC TREATMENT FOR CARDIOVASCULAR DISEASE
    Publication number: 20240062901
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: September 5, 2023
    Publication date: February 22, 2024
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • DETERMINING LIKELY RESPONSE TO COMBINATION THERAPIES FOR CARDIOVASCULAR DISEASE NON-INVASIVELY
    Publication number: 20240046457
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: August 9, 2023
    Publication date: February 8, 2024
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease
    Patent number: 11887701
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: January 30, 2024
    Assignee: Elucid Bioimaging Inc.
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease
    Patent number: 11887734
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: January 30, 2024
    Assignee: Elucid Bioimaging Inc.
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease
    Patent number: 11887713
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: January 30, 2024
    Assignee: Elucid Bioimaging Inc.
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • SYSTEMS AND METHODS TO AID CLINICAL DECISION SUPPORT FOR ANTI-INFLAMMATORY AND PRO-RESOLVING THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20240021306
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: September 5, 2023
    Publication date: January 18, 2024
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • Non-invasive determination of likely response to combination therapies for cardiovascular disease
    Patent number: 11869186
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: January 9, 2024
    Assignee: Elucid Bioimaging Inc.
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • CLINICAL DECISION SUPPORT TO AID INTERVENTIONAL VS MEDICAL THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20240006066
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: September 7, 2023
    Publication date: January 4, 2024
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • SCREENING CANDIDATE DYSLIPIDEMIA AGENTS
    Publication number: 20230420143
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: August 30, 2023
    Publication date: December 28, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • CLINICAL DECISION SUPPORT TO AID DYSLIPIDEMIA THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20230420130
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: September 1, 2023
    Publication date: December 28, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • SCREENING POTENTIAL SUBJECTS FOR ENROLLMENT IN DYSLIPIDEMIA THERAPY CLINICAL TRIALS
    Publication number: 20230420144
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: August 30, 2023
    Publication date: December 28, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • CLINICAL DECISION SUPPORT TO AID WATCHFUL WAITING OF CARDIOVASCULAR DISEASE
    Publication number: 20230420131
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: September 7, 2023
    Publication date: December 28, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • DETERMINING LIKELY RESPONSE TO ANTI-INFLAMMATORY AND PRO-RESOLVING THERAPIES FOR CARDIOVASCULAR DISEASE NON-INVASIVELY
    Publication number: 20230386634
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: August 9, 2023
    Publication date: November 30, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • DETERMINING LIKELY RESPONSE TO GLYCEMIC TREATMENT FOR CARDIOVASCULAR DISEASE NON-INVASIVELY
    Publication number: 20230386633
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: August 9, 2023
    Publication date: November 30, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease
    Patent number: 11791027
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: October 17, 2023
    Assignee: Elucid Bioimaging Inc.
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • VIRTUAL TRANSCRIPTOMICS
    Publication number: 20230290433
    Abstract: Atherosclerotic plaque phenotyping by image data analysis, e.g., using conventional computed tomography angiography (CTA) or other imaging modalities can elucidate the molecular signature of atherosclerotic lesions on a per-patient basis.
    Type: Application
    Filed: March 11, 2022
    Publication date: September 14, 2023
    Inventors: Andrew J. Buckler, Ljubica Matic, Ulf Hedin
  • IN SILICO SYSTEMS BIOLOGY MODEL OF LIPID-LOWERING THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20230245775
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 3, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • APPLICATIONS TO OPTIMIZE BENEFIT OF LIPID LOWERING THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20230207137
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: March 1, 2023
    Publication date: June 29, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips
  • NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO ANTI-DIABETIC THERAPIES FOR CARDIOVASCULAR DISEASE
    Publication number: 20230005583
    Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
    Type: Application
    Filed: June 10, 2022
    Publication date: January 5, 2023
    Inventors: Andrew J. Buckler, Ulf Hedin, Ljubica Matic, Matthew Phillips